{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:59:28Z","timestamp":1772665168716,"version":"3.50.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.1009","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T05:57:45Z","timestamp":1130479065000},"page":"1009-1012","source":"Crossref","is-referenced-by-count":12,"title":["Serum Amyloid A as a Potent Therapeutic Marker in a Refractory Patient with Polymyalgia Rheumatica"],"prefix":"10.2169","volume":"44","author":[{"given":"Yasuhiro","family":"SHIMOJIMA","sequence":"first","affiliation":[{"name":"Third Department of Medicine, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"GONO","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"ISHII","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ichi","family":"IKEDA","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Douglas WA, Martin BA, Morris JH. Polymyalgia rheumatica: an arthroscopic study of the shoulder joint. Ann Rheum Dis <b>42<\/b>: 311-316, 1983.","DOI":"10.1136\/ard.42.3.311"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chou CT, Schumacher HR Jr. Clinical and pathologic studies of synovitis in polymyalgia rheumatica. Arthritis Rheum <b>27<\/b>: 1107-1117, 1984.","DOI":"10.1002\/art.1780271005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V. Circulating CD8<SUP>+<\/SUP> T cells in polymyalgia rheumatica and giant cell arteritis: a review. Semin Arthritis Rheum <b>30<\/b>: 257-271, 2001.","DOI":"10.1053\/sarh.2001.9734"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med <b>159<\/b>: 577-584, 1999.","DOI":"10.1001\/archinte.159.6.577"},{"key":"5","unstructured":"5) Hachulla E, Saile R, Parra HJ, et al. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease. Clin Exp Rheumatol <b>9<\/b>: 157-163, 1991."},{"key":"6","unstructured":"6) Yamane T, Yamauchi H, Abe N, et al. Serum amyloid A as a useful index of disease activity in polymyalgia rheumatica. Ryumachi <b>43<\/b>: 544-548, 2003 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Cimmino MA, Salvarani C. Classification and assessment of rheumatic diseases: polymyalgia rheumatica and giant cell arteritis. Baillieres Clin Rheumatol <b>9<\/b>: 515-527, 1995.","DOI":"10.1016\/S0950-3579(05)80256-0"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.254.19.2763"},{"key":"9","unstructured":"9) Oide T, Ohara S, Oguchi K, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients. Clin Exp Rheumatol <b>22<\/b>: 91-98, 2004."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cimmino MA, Silvestri E, Garlaschi G. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) as recurrence of aborted PMR. Ann Rheum Dis <b>60<\/b>: 303, 2001.","DOI":"10.1136\/ard.60.3.303"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum <b>31<\/b>: 315-324, 1988.","DOI":"10.1002\/art.1780310302"},{"issue":"4","key":"12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/CCLM.1999.063","volume":"37","author":"YAMADA T","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/1434-6621","issn-type":"print"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.096"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Thorn CF, Lu ZY, Whitehead AS. Regulation of the human acute phase serum amyloid A genes by tumor necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol <b>59<\/b>: 152-158, 2004.","DOI":"10.1111\/j.0300-9475.2004.01369.x"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400607"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med <b>121<\/b>: 484-491, 1994.","DOI":"10.7326\/0003-4819-121-7-199410010-00003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Uddhammar A, Sundqvist KG, Ellis B, Rantapaa-Dahlqvist S. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol <b>37<\/b>: 766-769, 1998.","DOI":"10.1093\/rheumatology\/37.7.766"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Macchioni P, Boiardi L, Salvarani C, et al. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica\/ giant cell arteritis. Br J Rheumatol <b>32<\/b>: 666-670, 1993.","DOI":"10.1093\/rheumatology\/32.8.666"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis <b>63<\/b>: 54-60, 2004.","DOI":"10.1136\/ard.2003.005900"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Salvarani C, Boiardi L, Macchioni P, et al. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis <b>54<\/b>: 640-644, 1995.","DOI":"10.1136\/ard.54.8.640"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_1009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:22:51Z","timestamp":1621444971000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_1009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.1009","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}